SLC10A3 and neoplasm: When we classified the population into primary and recurrent tumor individuals, and the expression of SLC10A3 was not significantly different between the two subgroups among primary tumor population (Supplementary Figure 5B), but the expression of SLC10A3 was remarkably different between the two subgroups among recurrent tumor population (Supplementary Figure 5C).